Phase I trial of XR9576 in healthy volunteers demonstrates modulation of P-glycoprotein in CD56+ lymphocytes after oral and intravenous administration.
Year: 2000
Type: article
Study design: Clinical Trial
Source: PubMed
Authors: A Stewart, J Steiner, G Mellows, B Laguda, D Norris, P Bevan
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W1623543107